Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 10.70M
March 31, 2026 4.561M
December 31, 2025 6.351M
September 30, 2025 6.226M
June 30, 2025 7.086M
March 31, 2025 2.767M
December 31, 2024 2.896M
September 30, 2024 3.928M
Date Value
June 30, 2024 6.146M
March 31, 2024 0.4008M
December 31, 2023 1.304M
September 30, 2023 3.778M
June 30, 2023
March 31, 2023
December 31, 2022 0.1975M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. 443.12M
enGene Therapeutics, Inc. 266.40M
Xenon Pharmaceuticals, Inc. 930.69M
Psyence Biomedical Ltd. 7.197M
AVITA Medical, Inc. 11.14M